TNFSF11 and metastatic malignant neoplasm: Abnormal increases in the RANKL signaling cascade enhances osteoclast development and bone resorption activity, which in turn is associated with various bone diseases such as osteoporosis, metastatic cancers, and osteolytic bone destruction.